Texas Lawsuit Filed in Heparin Blood-Thinner Death
Relatives of a Texas man who died after receiving a contaminated dose of the blood thinner heparin have filed a lawsuit against the drug’s maker, the medical facility where the dose was administered, and others.
Lloyd James Robinson was given the anticoagulant heparin at the Lufkin Dialysis center, according to the lawsuit filed on Dec. 30. After the drug was administered, Robinson suffered a hypersensitivity-type adverse reaction and died, according to the lawsuit and a report in the Southeast Texas Record.
Heparin is widely used to prevent blood clots from forming during surgical procedures and to keep intravenous lines clear of blockages. In 2008, Baxter International Inc., a leading maker of heparin, announced a recall of all lots of the drug after it was determined that some doses were tainted with a counterfeit active ingredient provided by a Chinese manufacturer.
About 100 patient deaths and adverse reactions have been linked to the contaminated doses of heparin.
Robinson’s product-liability lawsuit accuses Baxter of using a Chinese manufacturer that did not adhere to United States regulations and of negligence for failing to act reasonably as a prudent drug manufacturer.
Also named as defendants in the lawsuit are Changzhou SPL Co., the Chinese manufacturer, American Capital, B. Braun Medical, Tyco Healthcare Group, Covidien Inc., Medefil Inc., Becton, Dickinson and Co., Rental Treatment Centers-Southeast, and Davita Inc., according to the Record report.
The lawsuit alleges as causes of action strict liability, fraudulent concealment, negligence, breach of implied and express warranties, intentional and negligent infliction of emotional distress, health care liability claim, wrongful death, and survival action claims, the Record reports.
Robinson’s surviving relatives are seeking financial damages for medical and hospital expenses, loss of income, physical and mental pain and suffering, loss of enjoyment of life, funeral and burial expenses, pecuniary losses, loss of advice and counsel, loss of services, loss of inheritance and loss of companionship and society.
The lawsuit will be transferred to the multidistrict litigation formed for heparin cases in the Northern District of Ohio for pretrial proceedings.
Related posts:
- Blood-Thinner Heparin Cost Man His Toes, Lawsuit Says An adverse reaction to the blood-thinning drug heparin cost a...
- Wrongful Death Lawsuit Filed in Blair Bathrobe Burn Death A lawsuit has been filed on behalf of an elderly...
- FDA Announces Changes to Potency of Blood Thinner Heparin The Food and Drug Administration today is alerting physicians and...
- Blood Thinner Heparin Was Intentionally Contaminated to Boost Company Profits, Lawsuit Claims Makers of the blood-thinning drug heparin intentionally used a counterfeit...
- More Deaths May be Linked to Controversial Blood Thinner Heparin Heparin, the blood-thinning drug that has been blamed for as...
